Biblioteca Humberto Rosselli Quijano
[artículo]
| Título : |
Mortality among parkinson’s disease patients treated with pimavanserin or atypical antipsychotics : an observational study in medicare beneficiaries |
| Tipo de documento: |
texto impreso |
| Autores: |
Andrew D. Mosholder, Autor ; Yong Ma, Autor ; Sandia Akhtar, Autor |
| Fecha de publicación: |
2022 |
| Artículo en la página: |
pp. 553-561 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Antipsicóticos, Epidemiología, Neurología |
| Resumen: |
Pimavanserin, a serotonin 5-HT2 antagonist, is indicated for treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. In premarketing trials in patients with Parkinson’s disease psychosis, 11% of patients died during open-label pimavanserin treatment. Antipsychotics, which are used off-label in Parkinson’s disease psychosis, increase mortality in dementia patients. |
| Link: |
./index.php?lvl=notice_display&id=28626 |
in The American Journal of Psychiatry > Año 2022 - Vol. 179 - No. 8 (Agosto) . - pp. 553-561
[artículo] Mortality among parkinson’s disease patients treated with pimavanserin or atypical antipsychotics : an observational study in medicare beneficiaries [texto impreso] / Andrew D. Mosholder, Autor ; Yong Ma, Autor ; Sandia Akhtar, Autor . - 2022 . - pp. 553-561. Idioma : Inglés ( eng) Idioma original : Inglés ( eng) in The American Journal of Psychiatry > Año 2022 - Vol. 179 - No. 8 (Agosto) . - pp. 553-561
| Palabras clave: |
Antipsicóticos, Epidemiología, Neurología |
| Resumen: |
Pimavanserin, a serotonin 5-HT2 antagonist, is indicated for treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. In premarketing trials in patients with Parkinson’s disease psychosis, 11% of patients died during open-label pimavanserin treatment. Antipsychotics, which are used off-label in Parkinson’s disease psychosis, increase mortality in dementia patients. |
| Link: |
./index.php?lvl=notice_display&id=28626 |
|
